Enzo Biochem (NYSE:ENZ) Posts Quarterly Earnings Results

Enzo Biochem (NYSE:ENZ) posted its quarterly earnings data on Monday. The medical research company reported ($0.05) earnings per share for the quarter, Zacks reports. Enzo Biochem had a negative return on equity of 11.84% and a negative net margin of 81.73%.

Enzo Biochem Price Performance

Shares of Enzo Biochem stock traded down $0.01 during trading on Monday, hitting $1.01. 45,663 shares of the company’s stock traded hands, compared to its average volume of 100,623. The firm’s fifty day moving average price is $1.09 and its 200 day moving average price is $1.11. Enzo Biochem has a twelve month low of $0.93 and a twelve month high of $1.50.

Enzo Biochem Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, December 2nd. Stockholders of record on Friday, November 15th were given a dividend of $0.10 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $0.40 annualized dividend and a dividend yield of 39.60%.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of Enzo Biochem in a research note on Monday, December 9th. They issued a “hold” rating for the company.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.